Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer
PARIS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® (INN: Piflufolastat (18F) also known as (18 F)-DCFPyL, indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical settings:
- Primary staging of patients with high-risk PCa prior to initial curative therapy
- To localize recurrence of PCa in patients with a suspected recurrence based on increasing serum prostate-specific antigen (PSA) levels after primary treatment with curative intent
Benoit Woessmer, PET Europe CEO at Curium commented: “We are thrilled that patients in Europe are finally able to benefit from PYLCLARI®, and in particular those patients in Greece via our strong partnership with SYN Innovation Laboratories. As a world leader in nuclear medicine, Curium is pleased to be improving the choice of diagnostic tools available to physicians in Greece to diagnose prostate cancer – ultimately for the benefit of prostate cancer patients.”
Savvas Thalasselis, Managing Director, SYN Innovation Laboratories SA commented: “Today’s announcement of the first dose of PYLCLARI® in Greece is an important milestone for the detection of prostate cancer, in particular for the primary staging of patients with high-risk prostate cancer prior to initial curative therapy. Our long-term partnership with Curium has demonstrated our commitment to diagnosing patients with cancer, and we look forward to further supporting Curium with their future pipeline of diagnostic and therapeutic products.”
Today’s announcement follows the decision in July 2023 by the European Commission granting marketing authorization for PYLCLARI® in the European Union. SYN Innovation Laboratories has been a partner with Curium since 2017, with exclusive manufacturing and distribution rights for Curium’s wide range of positron emission tomography products in Greece. SYN Innovation Laboratories will manufacture PYLCLARI® at its facilities in Athens, Greece.
For more information about PYLCLARI®: www.pylclari.com
About Curium
Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service.
With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive materials researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. To learn more, visit www.curiumpharma.com
For more information:
Ross Bethell, VP, Head of Global Communications
Curium
communications@curiumpharma.com
About SYN Innovation Laboratories:
It is based in Attica, Greece and is importing and marketing pharmaceutical and radiopharmaceutical products, medical equipment, biotechnology and special nutritional products, with the aim of diagnosing and treating patients with cancer or rare diseases. By supplying hospitals and diagnostic centers has a leading position in the diagnostic imaging sector (MRI, CT, Cath Lab, SPECT,PET)
For more information:
Savvas Thalasselis, Managing Director
SYN Innovation Laboratories SA
Tel: +30-216 9390105
info@syn-lab.gr
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Signify announces new customer-centric organization and structural cost reductions1.12.2023 08:00:00 CET | Press release
Press Release December 1, 2023 Signify announces new customer-centric organization and structural cost reductions New operating model includes four verticalized businesses to enhance customer-centricity and speed of executionStructural measures to reduce non-manufacturing costs, generating expected annualized savings in excess of €200mChanges to be implemented through 2024 Eindhoven, the Netherlands –Signify (Euronext: LIGHT), the world leader in lighting, announces it is adapting its organization to enhance customer-centricity, speed of execution and reduce its structural costs. “After the major transformation we achieved through the past decade, we are taking the next step by organizing our company around four vertically integrated businesses. Three of these will focus on customers: Professional, OEM and Consumer. The fourth will be dedicated to conventional lighting technologies. Aligned to the new customer-centric structure, we will further adjust the size of our central organizati
eQ Community Properties Fund divests 15 properties for 75 million euros1.12.2023 08:00:00 CET | Press release
Press release 1 December 2023 at 9:00 am eQ Community Properties Fund has sold a portfolio of 15 care properties to a fund managed by Northern Horizon. The purchase price of the portfolio is EUR 75 million. “The property transaction market remains slow. This transaction, however, provides good evidence that the social infrastructure segment is attractive also in the present market sentiment. After this transaction nearly 70% of the fund’s 120 properties is located in the capital and Tampere region, and the remaining part in university cities. The number of properties in the portfolio will decrease and at the same time the unit size will increase, making the Fund's operations more efficient. Northern Horizon, as a buyer, is a respected player as an owner of care properties." says Tero Estovirta, Head of Real Estate Investments at eQ Asset Management. eQ Community Properties Fund was established in 2012. The value of the assets managed by the Fund amounted to 2.1 billion euros at the end
International Petroleum Corporation Announces TSX Approval for Renewal of Normal Course Issuer Bid1.12.2023 08:00:00 CET | Press release
International Petroleum Corporation ("IPC" or the "Corporation") (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that the Toronto Stock Exchange (the "TSX") has approved IPC's notice of intention to renew the Corporation's normal course issuer bid (the "NCIB"). Under the NCIB, the Corporation is authorized to purchase, through the facilities of the TSX and/or Nasdaq Stockholm, or as otherwise permitted under Canadian securities laws, as and when considered advisable by IPC, up to 8,342,119 common shares in the capital of the Corporation (the "Common Shares"), representing approximately 6.50% of the 128,224,820 Common Shares outstanding as at November 22, 2023 (or 10% of IPC's "public float" (as defined in the TSX Company Manual) of 83,421,196 Common Shares as at November 22, 2023), over a period of twelve months commencing on December 5, 2023 and ending on December 4, 2024, or until such earlier date as the NCIB is completed or terminated by IPC. The maximum number of Common Share
Nokia Corporation Financial Calendar for 20241.12.2023 07:00:00 CET | Press release
Nokia Corporation Stock Exchange Release 1 December 2023 at 8:00 EET Nokia Corporation Financial Calendar for 2024 Espoo, Finland – In this stock exchange release, Nokia provides its financial calendar for 2024, which includes the planned publication dates of its financial reports. Planned publication dates for Nokia's financial reports in 2024: report for Q4 2023 and full year 2023: 25 January 2024report for Q1 2024: 18 April 2024report for Q2 2024 and half-year 2024: 18 July 2024report for Q3 2024 and January–September 2024: 17 October 2024 Publication of "Nokia in 2023" Nokia plans to publish its "Nokia in 2023" annual report, which includes the review by the Board of Directors and the audited annual accounts, during the week starting on 26 February 2024. Nokia's Annual General Meeting Nokia's Annual General Meeting 2024 is planned to be held on 3 April 2024. About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are p
S&P Global Ratings raises its rating on CNH Industrial to ‘BBB+’1.12.2023 07:00:00 CET | Press release
Basildon, December 1, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that on November 30, 2023, S&P Global Ratings raised its long-term issuer credit ratings on CNH Industrial N.V. and its subsidiary, CNH Industrial Capital LLC, to 'BBB+' from 'BBB'. S&P Global Ratings also affirmed the 'A-2' short-term issuer credit rating. Additionally, S&P Global Ratings raised the issue-level ratings on CNH Industrial N.V. and its industrial subsidiaries' debt, as well as the issue-level ratings on CNH Industrial Capital LLC's senior unsecured debt, to 'BBB+' from 'BBB'. The outlook is stable. CNH Industrial (NYSE: CNHI / MI: CNHI) is a world-class equipment and services company. Driven by its purpose of Breaking New Ground, which centers on Innovation, Sustainability and Productivity, the Company provides the strategic direction, R&D capabilities, and investments that enable the success of its global and regional Brands. Globally, Case IH and New Holland Agriculture supply 360° agricul